Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 9,308 | 11,255 | 13,789 | 18,647 | 17,614 |
| Operating Income | -9,308 | -9,255 | -13,789 | -18,647 | -17,614 |
| Other Income | 2,964 | -529 | -1,989 | -64 | 2,280 |
| Pre-tax Income | -6,344 | -9,784 | -15,778 | -18,711 | -15,334 |
| Net Income Continuous | -6,344 | -9,784 | -15,778 | -18,711 | -15,334 |
| Net Income | $-6,344 | $-9,784 | $-15,778 | $-18,711 | $-15,334 |
| EPS Basic Total Ops | -4.22 | -7.84 | -13.50 | -16.00 | -13.16 |
| EPS Basic Continuous Ops | -4.22 | -8.08 | -13.43 | -15.99 | -13.16 |
| EPS Diluted Total Ops | -4.22 | -7.84 | -13.50 | -16.00 | -13.16 |
| EPS Diluted Continuous Ops | -4.22 | -8.08 | -13.43 | -15.99 | -13.16 |
| EPS Diluted Before Non-Recurring Items | N/A | -8.00 | -13.50 | -15.50 | -14.50 |
| EBITDA(a) | $-9,188 | $-11,236 | $-13,733 | $-18,532 | $-17,431 |